HomeZNTL • NASDAQ
Follow
Zentalis Pharmaceuticals Inc
Previous close
$12.88
Day range
$12.58 - $13.31
Year range
$9.56 - $31.46
Market cap
901.90M USD
Avg Volume
812.14K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 67.92M | 31.24% |
Net income | -60.92M | -10.82% |
Net profit margin | — | — |
Earnings per share | -0.83 | 9.78% |
EBITDA | -67.58M | -31.50% |
Effective tax rate | 0.22% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 482.92M | 10.41% |
Total assets | 551.69M | 2.30% |
Total liabilities | 114.30M | 8.56% |
Total equity | 437.39M | — |
Shares outstanding | 70.96M | — |
Price to book | 2.08 | — |
Return on assets | -29.86% | — |
Return on capital | -33.60% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -60.92M | -10.82% |
Cash from operations | -40.60M | -8.76% |
Cash from investing | -42.06M | -253.62% |
Cash from financing | 0.00 | -100.00% |
Net change in cash | -82.66M | -16,057.34% |
Free cash flow | -24.27M | -7.35% |
About
Founded
2014
Website
Employees
124